SQM (ADR)
Transforms Chilean brine and caliche plus Australian hard rock into lithium, iodine, and specialty chemicals.
Something off on this page? Send us feedback.
Profile
Produces lithium and derivatives, iodine, specialty plant nutrients, potassium products, and industrial chemicals from Chilean caliche and brine plus Australian hard rock. Integrated processing reaches multiple chemical markets, while products from Salar de Atacama generate roughly half of revenue and now operate through the state-partnered Nova Andino Litio venture.
Produces lithium carbonate and hydroxide, iodine and derivatives, specialty plant nutrients, potassium products, and industrial chemicals. Northern Chilean caliche supplies nitrates and iodine, Salar de Atacama brine supplies lithium and potassium, and Western Australian spodumene supports a second lithium chain linked to Kwinana refining.
Integrated extraction and conversion turn three mineral systems into multiple chemical products. Production remains concentrated in Chile, while Australia adds hard-rock lithium and China adds conversion capacity. The portfolio spans several end markets rather than relying on lithium alone.
Products originating in Salar de Atacama generate roughly half of revenue. Those operations sit inside Nova Andino Litio under long-dated Corfo contracts, with SQM initially retaining operating control before Codelco assumes it. Environmental obligations require staged reductions in brine and industrial-water extraction, and the Australian refinery remains in ramp-up.
Company facts
Categories
Key statistics
Year to date +12.8% · Average volume (30d) 921.8K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Citigroup | Upgrade | Neutral | Buy | ||
| Aug 24, 2026 | Scotiabank | Reiterate | Outperform | $93 | $104 | |
| Aug 20, 2026 | Deutsche Bank | Target | $98 | $94 | ||
| Jul 28, 2026 | Scotiabank | Reiterate | Sector Outperform | $105 | $93 | |
| Jul 15, 2026 | Goldman Sachs | Reiterate | Neutral | $100 | $82 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026Q2 FY26 | $2.03 | $2.31 | +13.8% | $2.24B | $2.47B | +10.3% | +4.07% |
| Aug 18, 2026Q2 FY26 | $2.03 | $2.31 | +13.8% | $2.24B | — | — | −0.84% |
| May 26, 2026Q1 FY26 | $1.78 | $1.28 | −28.1% | $1.69B | $1.76B | +3.9% | +4.36% |
| Feb 27, 2026Q4 FY25 | $0.75 | $0.64 | −14.7% | $1.25B | $1.32B | +5.6% | −0.88% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.04B | $1.04B | $1.17B | $1.34B | $1.76B | $2.47B | |
| Gross profit | $304.7M | $253.6M | $345.8M | $455.5M | $778.6M | $1.26B | |
| Operating income | $244.9M | $166.2M | $289.3M | $398.1M | $729.7M | $1.21B | |
| Net income | $137.5M | $88.4M | $178.4M | $185.4M | $364.7M | $660.1M | |
| Diluted EPS | $0.48 | $0.31 | $0.62 | $0.65 | $1.28 | $2.31 | |
| Gross margin | 29.4% | 24.3% | 29.5% | 34.1% | 44.2% | 51.1% | |
| Operating margin | 23.6% | 15.9% | 24.7% | 29.8% | 41.5% | 48.9% |
Fiscal years (4-quarter sums)FY21 $2.86B · FY22 $10.71B · FY23 $7.47B · FY24 $4.53B · FY25 $4.59B
Revenue by product · FY25
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $4.33B · Total debt $5.29B · Total assets $16.58B · Shareholders' equity $6.29B
Dividends
Last raised to $1.018 from $0.2216 in May 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| May 8, 2026 | May 8 | May 28 | $1.018 | raised from $0.2216 |
| May 9, 2024 | May 10 | May 28 | $0.2216 | cut from $0.4962 |
| Dec 6, 2023 | Dec 7 | Jan 5 | $0.4962 | cut from $0.6096 |
| Nov 2, 2023 | Nov 3 | Nov 21 | $0.6096 | cut from $0.7876 split-adjusted |
| Jul 13, 2023 | Jul 14 | Jul 31 | $0.7724 | cut from $3.1452 |
| May 11, 2023 | May 12 | May 31 | $3.1452 | raised from $3.0806 split-adjusted |
| Dec 8, 2022 | Dec 9 | Dec 27 | $2.9747 | raised from $1.849 split-adjusted |
| Sep 29, 2022 | Sep 30 | Oct 28 | $1.8525 | cut from $2.5962 |
Ownership
Shares outstanding 285.64M · Float 104.33M · 36.5% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Baillie Gifford & Co | 4.73M | 1.66% | 13F | Aug 6, 2026 |
| Van Eck Associates Corp | 2.66M | 0.93% | 13F | Aug 14, 2026 |
| BlackRock, Inc. | 2.37M | 0.83% | 13F | Aug 7, 2026 |
| Earnest Partners LLC | 2.10M | 0.74% | 13F | Aug 13, 2026 |
| Grantham, Mayo, van Otterloo & Co. LLC | 1.61M | 0.56% | 13F | Aug 13, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Albemarle
Major lithium-chemicals rival across carbonate and hydroxide
- ICL
Broad overlap in potash and specialty crop nutrition
- Rio Tinto (ADR)
Scaled lithium platform built around Arcadium and new projects
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| SQM (ADR) | $78.54 | −0.17% | $22.46B | 16.2 | 9.8 | 3.3 | +136.7% |
| Albemarle | $137.96 | +0.45% | $16.20B | — | 13.9 | 2.7 | +31.1% |
| ICL | $5.71 | +2.06% | $7.23B | 23.3 | 12.6 | 0.9 | +16.5% |
| Rio Tinto (ADR) | $103.71 | +0.37% | $167.86B | 13.9 | — | 2.7 | +14.5% |
| Median | 18.6 | 13.3 | 2.7 | +16.5% |